Statistics for Bright Minds Biosciences (id:579 DRUG)

Valuation metrics

Market cap

391.41M

Enterprise value

262.59M

Trailing P/E (ttm)

0.32

Forward P/E

PEG ratio

Price/Sales (ttm)

Price/Book (mrq)

41.08

Enterprise Value/Revenue

Enterprise Value/EBITDA

-35.83

Overview

Shares outstanding

6.08M

Float

631.10K

Shares short

7.03K

% Held by insiders

0.27%

% Held by institutions

0.38%

Average volume (10 days)

13.13K

Average volume (90 days)

Price summary

52-Week low

1.29

52-Week high

108.00

52-Week change

96.24%

Beta

1.13

50-Day moving average

30.23

200-Day moving average

8.79

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

July 14th, 2023

Financials

Fiscal year

Fiscal year ends

September 30th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-28.86%

Return on equity

-51.80%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-3,580,629.00

Diluted EPS (ttm)

-0.88

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

6.19M

Total cash per share (mrq)

1.39

Total debt (mrq)

14.02K

Total Debt/Equity (mrq)

0.23

Current ratio (mrq)

3.51K%

Book value per share (mrq)

1.37

Cash flow

Cash flow statement

-2,584,540.00

Levered free cash flow (LFCF)

-1,337,075.00